Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of 25 mg eltrombopag film-coated tablets in healthy Thai volunteers
TCTR20221107003Phase 1Completed
- Sponsor
- Unison Laboratories
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of eltrombopag (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax and truncated AUC0-72. Started Feb 2023; status: completed.
02
Drugs
eltrombopag
Beyond the preview
Go deeper on TCTR20221107003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221107003.